Overview
🌐 Website: simulations-plus.com
💲 Revenue:
📍 Address: United States
👥 Employees:
🗓️ Established: 1996
📅 Published: December 20, 2014
✏️ Last updated: November 21, 2025
Simulations Plus
AskAI Summary of Simulations Plus
Generated using ISVWorld's AskAI proprietary software industry model.
📝 AskAI Recap: Simulations Plus develops and sells a wide range of proprietary modeling and simulation software products supporting drug discovery and development, including AI-driven drug design, PBPK, QSP/QST, and cheminformatics tools, along with expert consulting services.
💬 Inclusion Rationale: The company develops and sells multiple standalone and SaaS software products such as GastroPlus®, ADMET Predictor®, DILIsym®, and others, focused on pharmaceutical modeling and simulation. This clearly qualifies it as an ISV engaged in developing and commercializing software products rather than providing only custom software development or services.
Contacts
Access available business contacts and professional information associated with Simulations Plus through the interactive ISVWorld profile.
Similar Companies
Explore companies similar to Simulations Plus based on software focus, industries, technologies, and market positioning.
Classifications
Company Tags
External Profiles
Scores
Company News
View the latest company news, product announcements, partnerships, and business developments related to Simulations Plus.
Relevant Industry News
Explore market and industry news relevant to Simulations Plus and its software categories.
Funding
Review available funding rounds, investors, acquisitions, and financing activity associated with Simulations Plus.
